Showing results (41-50 of 167) with videos related to
Sort By:
Pageof 17
Nature Reviews. Drug Discovery|March 25, 2021
Antisense technology: an overview and prospectusStanley T Crooke, Brenda F Baker, Rosanne M Crooke, et al.Nucleic Acids Research|July 6, 2016
Annexin A2 facilitates endocytic trafficking of antisense oligonucleotidesShiyu Wang, Hong Sun, Michael Tanowitz, et al.Nucleic Acids Research|April 6, 2017
Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotidesShiyu Wang, Hong Sun, Michael Tanowitz, et al.Proceedings of the American Philosophical Society|February 3, 2015
The origin of bounded rationality and intelligenceAndrew W LoJournal of the American Chemical Society|May 7, 2020
Interaction of ASOs with PC4 Is Highly Influenced by the Cellular Environment and ASO ChemistryTimothy A Vickers, Michael T Migawa, Punit P Seth, et al.Journal of the American Chemical Society|August 14, 2020
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These AgentsStanley T Crooke, Punit P Seth, Timothy A Vickers, et al.Nucleic Acid Therapeutics|February 10, 2021
Hsc70 Facilitates Mannose-6-Phosphate Receptor-Mediated Intracellular Trafficking and Enhances Endosomal Release of Phosphorothioate-Modified Antisense OligonucleotidesXue-Hai Liang, Joshua G Nichols, Chih-Wei Hsu, et al.Molecular Therapy. Nucleic Acids|June 6, 2022
RNA modifications can affect RNase H1-mediated PS-ASO activityKatelyn A Doxtader Lacy, Xue-Hai Liang, Lingdi Zhang, et al.Cell Metabolism|April 5, 2018
RNA-Targeted TherapeuticsStanley T Crooke, Joseph L Witztum, C Frank Bennett, et al.Plos One|August 31, 2013
Human RNase H1 is associated with protein P32 and is involved in mitochondrial pre-rRNA processingHongjiang Wu, Hong Sun, Xuehai Liang, et al.Pageof 17